Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,486Revenue $M74.0Net Margin (%)-150.0Z-Score-0.2
Enterprise Value $M1,625EPS $-2.3Operating Margin %-10.4F-Score4
P/E(ttm))0Cash Flow Per Share $-1.7Pre-tax Margin (%)-151.6Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %0Quick Ratio1.2Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %0Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-77.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-468.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M74.8ROI % (ttm)-72.1Gross Margin Increase y-yY

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
($11.52)
$ 12.58%Add 39.93%80,834
HZNPJoel Greenblatt 2014-06-30 Buy 0.01%$12.02 - $16.32
($14.25)
$ 12.5-12%New holding, 57769 sh.57,769
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
HZNP Joel Greenblatt 2014-09-3080,8340.110.01+39.93%
Premium Most recent portfolio changes are included for Premium Members only!


HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Walbert Timothy PChairman, President and CEO 2014-11-19Sell150,000$12.051.58view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2014-11-19Sell24,999$12.051.58view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.051.58view
Nohria VirinderDirector 2014-11-13Sell1,739,130$11.546.07view
VENKATARAMAN BALAJIFormer 10% Owner 2014-11-13Sell6,086,957$11.546.07view
Nohria VirinderDirector 2014-11-13Sell2,000,000$11.546.07view
Kelly David GeorgeEVP & Corporate Secretary 2014-11-06Sell0$06.07view
DE VAERE ROBERT JEVP & CFO 2014-09-30Sell51,942$12.28-0.33view
DE VAERE ROBERT JEVP & CFO 2014-05-19Sell12,939$12.94-5.41view
SHERMAN JEFFREY WEVP & Chief Medical Officer 2014-05-19Sell9,361$12.94-5.41view

Press Releases about HZNP :

    Quarterly/Annual Reports about HZNP:

    News about HZNP:

    Articles On GuruFocus.com
    Horizon Pharma plc to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 24 2014 
    Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary Shares by Selling Shareholder Nov 14 2014 
    Horizon Pharma plc Announces Proposed Secondary Offering of Ordinary Shares by Selling Shareholders Nov 13 2014 
    Horizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release Table Nov 12 2014 
    Horizon Pharma plc Appoints John J. Kody as Executive Vice President and Chief Commercial Officer Nov 06 2014 
    Horizon Pharma plc Announces DUEXIS(R) Selected as Winner of Chicago Innovation Award Oct 31 2014 
    Horizon Pharma plc Announces Acquisition of U.S. Rights to PENNSAID(R) 2% From Nuvo Research Inc. Oct 17 2014 
    Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notice of A Oct 15 2014 
    Horizon Pharma plc Reviews Future ACTIMMUNE(R) Opportunities at Analyst Day Oct 15 2014 
    Horizon Pharma plc Receives Orphan-Drug Designation for ACTIMMUNE(R) (Interferon gamma-1b) in Friedr Oct 15 2014 

    More From Our Partners
    InsiderInsights.com Daily Round Up 11/17/14: SFM, INTX, GNRC, GSAT Nov 18 2014 - SEEKINGALPHA

    More From Other Websites
    Horizon Pharma plc to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 24 2014
    Horizon Pharma plc to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 24 2014
    Horizon Pharma plc Announces Presentation of Data Showing Unmet Need in Rheumatoid Arthritis and the... Nov 18 2014
    Horizon Pharma plc Announces Presentation of Data Showing Unmet Need in Rheumatoid Arthritis and the... Nov 18 2014
    HORIZON PHARMA PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 14 2014
    HORIZON PHARMA PLC Financials Nov 14 2014
    Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary Shares by Selling... Nov 14 2014
    Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary Shares by Selling... Nov 14 2014
    HORIZON PHARMA PLC Files SEC form 8-K, Other Events Nov 13 2014
    Horizon Pharma plc Announces Proposed Secondary Offering of Ordinary Shares by Selling Shareholders Nov 13 2014
    Horizon Pharma plc Announces Proposed Secondary Offering of Ordinary Shares by Selling Shareholders Nov 13 2014
    Horizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and... Nov 12 2014
    Horizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and... Nov 12 2014
    HORIZON PHARMA PLC Files SEC form 8-K, Other Events Nov 12 2014
    Horizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release... Nov 12 2014
    Horizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release... Nov 12 2014
    Horizon Pharma plc to Present at the Stifel 2014 Healthcare Conference Nov 11 2014
    HORIZON PHARMA PLC Files SEC form 8-K, Change in Directors or Principal Officers Nov 10 2014
    10-Q for Horizon Pharma, Inc. Nov 09 2014
    Horizon Pharma (HZNP) Is Weak On High Volume Today Nov 07 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK